206 related articles for article (PubMed ID: 26504855)
1. Autoimmune Conditions in 235 Hemochromatosis Probands with HFE C282Y Homozygosity and Their First-Degree Relatives.
Barton JC; Barton JC
J Immunol Res; 2015; 2015():453046. PubMed ID: 26504855
[TBL] [Abstract][Full Text] [Related]
2. HLA haplotype A*03-B*07 in hemochromatosis probands with HFE C282Y homozygosity: frequency disparity in men and women and lack of association with severity of iron overload.
Barton JC; Wiener HW; Acton RT; Go RC
Blood Cells Mol Dis; 2005; 34(1):38-47. PubMed ID: 15607698
[TBL] [Abstract][Full Text] [Related]
3. Longer survival associated with HLA-A*03, B*14 among 212 hemochromatosis probands with HFE C282Y homozygosity and HLA-A and -B typing and haplotyping.
Barton JC; Barton JC; Acton RT
Eur J Haematol; 2010 Nov; 85(5):439-47. PubMed ID: 20722701
[TBL] [Abstract][Full Text] [Related]
4. Diabetes in first-degree family members: a predictor of type 2 diabetes in 159 nonscreening Alabama hemochromatosis probands with HFE C282Y homozygosity.
Barton JC; Barton JC; Acton RT
Diabetes Care; 2014; 37(1):259-66. PubMed ID: 23990522
[TBL] [Abstract][Full Text] [Related]
5. Non-alcoholic fatty liver disease in hemochromatosis probands with iron overload and HFE p.C282Y/p.C282Y.
Barton JC; Barton JC; Acton RT
BMC Gastroenterol; 2023 Apr; 23(1):137. PubMed ID: 37118679
[TBL] [Abstract][Full Text] [Related]
6. Common variable immunodeficiency and IgG subclass deficiency in central Alabama hemochromatosis probands homozygous for HFE C282Y.
Barton JC; Bertoli LF; Acton RT
Blood Cells Mol Dis; 2003; 31(1):102-11. PubMed ID: 12850493
[TBL] [Abstract][Full Text] [Related]
7. Effect of Native American ancestry on iron-related phenotypes of Alabama hemochromatosis probands with HFE C282Y homozygosity.
Barton JC; Barton EH; Acton RT
BMC Med Genet; 2006 Mar; 7():22. PubMed ID: 16533407
[TBL] [Abstract][Full Text] [Related]
8. Increased risk of death from iron overload among 422 treated probands with HFE hemochromatosis and serum levels of ferritin greater than 1000 μg/L at diagnosis.
Barton JC; Barton JC; Acton RT; So J; Chan S; Adams PC
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):412-6. PubMed ID: 22265917
[TBL] [Abstract][Full Text] [Related]
9. HLA-A*03, the hemochromatosis ancestral haplotype, and phenotypes of referred hemochromatosis probands with HFE p.C282Y homozygosity.
Barton JC; Barton JC; Acton RT
Hereditas; 2022 Jun; 159(1):25. PubMed ID: 35659379
[TBL] [Abstract][Full Text] [Related]
10. Correlation between iron status and genetic hemochromatosis (codon C282Y) in a large German population.
Wrede CE; Hutzler S; Bollheimer LC; Buettner R; Hellerbrand C; Schöelmerich J; Palitzsch KD
Isr Med Assoc J; 2004 Jan; 6(1):30-3. PubMed ID: 14740507
[TBL] [Abstract][Full Text] [Related]
11. Abdominal pain and cirrhosis at diagnosis of hemochromatosis: Analysis of 219 referred probands with HFE p.C282Y homozygosity and a literature review.
Barton JC; Barton JC; Patel N; McLaren GD
PLoS One; 2021; 16(12):e0261690. PubMed ID: 34932603
[TBL] [Abstract][Full Text] [Related]
12. The clinical relevance of compound heterozygosity for the C282Y and H63D substitutions in hemochromatosis.
Walsh A; Dixon JL; Ramm GA; Hewett DG; Lincoln DJ; Anderson GJ; Subramaniam VN; Dodemaide J; Cavanaugh JA; Bassett ML; Powell LW
Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1403-10. PubMed ID: 16979952
[TBL] [Abstract][Full Text] [Related]
13. A population-based study of the clinical expression of the hemochromatosis gene.
Olynyk JK; Cullen DJ; Aquilia S; Rossi E; Summerville L; Powell LW
N Engl J Med; 1999 Sep; 341(10):718-24. PubMed ID: 10471457
[TBL] [Abstract][Full Text] [Related]
14. HFE C282Y homozygosity is associated with lower total and low-density lipoprotein cholesterol: The hemochromatosis and iron overload screening study.
Adams PC; Pankow JS; Barton JC; Acton RT; Leiendecker-Foster C; McLaren GD; Speechley M; Eckfeldt JH
Circ Cardiovasc Genet; 2009 Feb; 2(1):34-7. PubMed ID: 20031565
[TBL] [Abstract][Full Text] [Related]
15. [Molecular genetic diagnostics and screening of hereditary hemochromatosis].
Zlocha J; Kovács L; Pozgayová S; Kupcová V; Durínová S
Vnitr Lek; 2006 Jun; 52(6):602-8. PubMed ID: 16871764
[TBL] [Abstract][Full Text] [Related]
16. Decreased cardiovascular and extrahepatic cancer-related mortality in treated patients with mild HFE hemochromatosis.
Bardou-Jacquet E; Morcet J; Manet G; Lainé F; Perrin M; Jouanolle AM; Guyader D; Moirand R; Viel JF; Deugnier Y
J Hepatol; 2015 Mar; 62(3):682-9. PubMed ID: 25450707
[TBL] [Abstract][Full Text] [Related]
17. IgG subclass levels in referred hemochromatosis probands with HFE p.C282Y/p.C282Y.
Barton JC; Barton JC; Bertoli LF; Acton RT
PLoS One; 2024; 19(5):e0302817. PubMed ID: 38743659
[TBL] [Abstract][Full Text] [Related]
18. Hemochromatosis and iron-overload screening in a racially diverse population.
Adams PC; Reboussin DM; Barton JC; McLaren CE; Eckfeldt JH; McLaren GD; Dawkins FW; Acton RT; Harris EL; Gordeuk VR; Leiendecker-Foster C; Speechley M; Snively BM; Holup JL; Thomson E; Sholinsky P;
N Engl J Med; 2005 Apr; 352(17):1769-78. PubMed ID: 15858186
[TBL] [Abstract][Full Text] [Related]
19. Iron-overload-related disease in HFE hereditary hemochromatosis.
Allen KJ; Gurrin LC; Constantine CC; Osborne NJ; Delatycki MB; Nicoll AJ; McLaren CE; Bahlo M; Nisselle AE; Vulpe CD; Anderson GJ; Southey MC; Giles GG; English DR; Hopper JL; Olynyk JK; Powell LW; Gertig DM
N Engl J Med; 2008 Jan; 358(3):221-30. PubMed ID: 18199861
[TBL] [Abstract][Full Text] [Related]
20. Morbidity and mortality in first-degree relatives of C282Y homozygous probands with clinically detected haemochromatosis compared with the general population: the HEmochromatosis FAmily Study (HEFAS).
Jacobs EM; Hendriks JC; Marx JJ; van Deursen CT; Kreeftenberg HG; de Vries RA; Stalenhoef AF; Verbeek AL; Swinkels DW
Neth J Med; 2007 Dec; 65(11):425-33. PubMed ID: 18079565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
